Becton Dickinson and Company Total Liabilities
Becton Dickinson and Company total liabilities. Based on the latest financial reports, Becton Dickinson and Company (BDX) has total liabilities worth $26.31 Billion USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Becton Dickinson and Company (BDX) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Becton Dickinson and Company (1985–2025)
Total liabilities of Becton Dickinson and Company from 1985 to 2025. This chart illustrates how Becton Dickinson and Company's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of Becton Dickinson and Company to see how much of total assets are deployed in long-term investments.
Becton Dickinson and Company Competitors by Total Liabilities
The table below lists competitors of Becton Dickinson and Company ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Franco-Nevada Corporation
TO:FNV
|
Canada | CA$680.39 Million |
|
Ford Motor Company
NYSE:F
|
USA | $249.78 Billion |
|
DnB ASA
OL:DNB
|
Norway | Nkr3.60 Trillion |
|
Autodesk Inc
NASDAQ:ADSK
|
USA | $8.30 Billion |
|
Itaú Unibanco Holding S.A.
SA:ITUB3
|
Brazil | R$2.97 Trillion |
|
Nasdaq Inc
NASDAQ:NDAQ
|
USA | $18.82 Billion |
|
MicroStrategy Incorporated
NASDAQ:MSTR
|
USA | $7.24 Billion |
|
Waste Connections Inc
TO:WCN
|
Canada | CA$13.46 Billion |
Liability Composition Analysis (1985–2025)
This chart breaks down Becton Dickinson and Company's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Becton Dickinson and Company (BDX) total assets.
Liquidity & Leverage Metrics
Becton Dickinson and Company Total Liabilities Ratios Explained
Becton Dickinson and Company total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.87 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Becton Dickinson and Company's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Becton Dickinson and Company (1985–2025)
The table below shows the annual total liabilities of Becton Dickinson and Company from 1985 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $29.94 Billion | -4.65% |
| 2024-09-30 | $31.40 Billion | +16.36% |
| 2023-09-30 | $26.98 Billion | -2.42% |
| 2022-09-30 | $27.65 Billion | -8.45% |
| 2021-09-30 | $30.20 Billion | -0.15% |
| 2020-09-30 | $30.25 Billion | -1.42% |
| 2019-09-30 | $30.68 Billion | -6.77% |
| 2018-09-30 | $32.91 Billion | +32.78% |
| 2017-09-30 | $24.79 Billion | +38.07% |
| 2016-09-30 | $17.95 Billion | -7.05% |
| 2015-09-30 | $19.31 Billion | +161.20% |
| 2014-09-30 | $7.39 Billion | +4.04% |
| 2013-09-30 | $7.11 Billion | -1.63% |
| 2012-09-30 | $7.22 Billion | +28.97% |
| 2011-09-30 | $5.60 Billion | +32.88% |
| 2010-09-30 | $4.22 Billion | +1.30% |
| 2009-09-30 | $4.16 Billion | +39.78% |
| 2008-09-30 | $2.98 Billion | +0.34% |
| 2007-09-30 | $2.97 Billion | -0.70% |
| 2006-09-30 | $2.99 Billion | +4.90% |
| 2005-09-30 | $2.85 Billion | +6.11% |
| 2004-09-30 | $2.68 Billion | +0.35% |
| 2003-09-30 | $2.68 Billion | +4.81% |
| 2002-09-30 | $2.55 Billion | +3.19% |
| 2001-09-30 | $2.47 Billion | -2.96% |
| 2000-09-30 | $2.55 Billion | -4.47% |
| 1999-09-30 | $2.67 Billion | +19.54% |
| 1998-09-30 | $2.23 Billion | +31.70% |
| 1997-09-30 | $1.69 Billion | +8.33% |
| 1996-09-30 | $1.56 Billion | -2.28% |
| 1995-09-30 | $1.60 Billion | -4.57% |
| 1994-09-30 | $1.68 Billion | +2.89% |
| 1993-09-30 | $1.63 Billion | +3.03% |
| 1992-09-30 | $1.58 Billion | +11.76% |
| 1991-09-30 | $1.42 Billion | +4.14% |
| 1990-09-30 | $1.36 Billion | +13.46% |
| 1989-09-30 | $1.20 Billion | +8.21% |
| 1988-09-30 | $1.11 Billion | +7.52% |
| 1987-09-30 | $1.03 Billion | +16.14% |
| 1986-09-30 | $887.00 Million | +58.45% |
| 1985-09-30 | $559.80 Million | -- |
About Becton Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segme… Read more